Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1989-02-02
1990-10-30
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514 86, A61K 31675
Patent
active
049668951
ABSTRACT:
The present invention relates to a method for treating mammals having acquired immuno-deficiency syndrome (AIDS) or AIDS-related complex or who are infected with other retroviruses, which comprises the administration of a therapeutically effective amount of a cyclic monophosphate derivative of a purine or pyrimidine acyclonucleoside. Process for the preparation of such compounds and compositions containing such compounds as the active ingredient thereof are also disclosed.
REFERENCES:
patent: 4199574 (1980-04-01), Schaeffer
patent: 4287188 (1981-09-01), Schaeffer
patent: 4323573 (1982-04-01), Schaeffer
patent: 4495190 (1985-01-01), Hagberg et al.
patent: 4565868 (1986-01-01), Verheyden
patent: 4579849 (1986-04-01), MacCoss et al.
patent: 4590269 (1986-05-01), Prisbe et al.
patent: 4670424 (1987-06-01), MacCoss et al.
Bailey et al., J. Chem. Soc., pp. 2767-2775 (1988).
Pandit et al., Synthetic Communications, 2(6)345-351 (1972)
Maccoss Malcolm
Tolman Richard L.
Goldberg Jerome D.
Merck & Co. , Inc.
LandOfFree
Cyclic monophosphates of purine and pyrimidine acyclonucleosides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic monophosphates of purine and pyrimidine acyclonucleosides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic monophosphates of purine and pyrimidine acyclonucleosides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-275398